88 related articles for article (PubMed ID: 8798241)
1. Central muscarinic cholinergic M1 and M2 receptor changes in congenital ornithine transcarbamylase deficiency.
Ratnakumari L; Qureshi IA; Butterworth RF
Pediatr Res; 1996 Jul; 40(1):25-8. PubMed ID: 8798241
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
Tonnaer JA; Ernste BH; Wester J; Kelder K
J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
[TBL] [Abstract][Full Text] [Related]
3. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a central cholinergic deficit in congenital ornithine transcarbamylase deficiency.
Butterworth RF
Dev Neurosci; 1998; 20(4-5):478-84. PubMed ID: 9778587
[TBL] [Abstract][Full Text] [Related]
5. Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system.
Rossner S; Schliebs R; Perez-Polo JR; Wiley RG; Bigl V
J Neurosci Res; 1995 Jan; 40(1):31-43. PubMed ID: 7714924
[TBL] [Abstract][Full Text] [Related]
6. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
7. Evidence for forebrain cholinergic neuronal loss in congenital ornithine transcarbamylase deficiency.
Butterworth RF
Metab Brain Dis; 2000 Mar; 15(1):83-91. PubMed ID: 10885542
[TBL] [Abstract][Full Text] [Related]
8. Ornithine transcarbamylase deficiency: pathogenesis of the cerebral disorder and new prospects for therapy.
Michalak A; Butterworth RF
Metab Brain Dis; 1997 Sep; 12(3):171-82. PubMed ID: 9346466
[TBL] [Abstract][Full Text] [Related]
9. Alterations in muscarinic cholinergic receptor densities induced by thiamine deficiency: autoradiographic detection of changes in high- and low-affinity agonist binding.
Gehlert DR; Morey WA; Wamsley JK
J Neurosci Res; 1985; 13(3):443-52. PubMed ID: 3989884
[TBL] [Abstract][Full Text] [Related]
10. Loss of [3H]MK801 binding sites in brain in congenital ornithine transcarbamylase deficiency.
Ratnakumari L; Qureshi IA; Butterworth RF
Metab Brain Dis; 1995 Sep; 10(3):249-55. PubMed ID: 8830285
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in the density of muscarinic cholinergic M1 and M2 receptor subtypes in pyramidal neurons of the rat hippocampus.
Amenta F; Liu A; Giannella M; Pigini M; Tayebati SK; Zaccheo D
Eur J Histochem; 1995; 39(2):107-16. PubMed ID: 7549013
[TBL] [Abstract][Full Text] [Related]
12. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
Evans RA; Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156
[TBL] [Abstract][Full Text] [Related]
13. Compartment-specific changes in the density of choline and dopamine uptake sites and muscarinic and dopaminergic receptors during the development of the baboon striatum: a quantitative receptor autoradiographic study.
Lowenstein PR; Slesinger PA; Singer HS; Walker LC; Casanova MF; Raskin LS; Price DL; Coyle JT
J Comp Neurol; 1989 Oct; 288(3):428-46. PubMed ID: 2794143
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic cholinergic receptors in the hippocampus of aged rats: influence of choline alphoscerate treatment.
Amenta F; Liu A; Zeng YC; Zaccheo D
Mech Ageing Dev; 1994 Oct; 76(1):49-64. PubMed ID: 7845062
[TBL] [Abstract][Full Text] [Related]
15. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain.
Perry EK; Smith CJ; Perry RH; Whitford C; Johnson M; Birdsall NJ
J Chem Neuroanat; 1989; 2(4):189-99. PubMed ID: 2597358
[TBL] [Abstract][Full Text] [Related]
16. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
Flynn DD; Weinstein DA; Mash DC
Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
[TBL] [Abstract][Full Text] [Related]
17. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: forebrain.
Cortés R; Probst A; Palacios JM
Neuroscience; 1987 Jan; 20(1):65-107. PubMed ID: 3561769
[TBL] [Abstract][Full Text] [Related]
18. Evidence for cholinergic neuronal loss in brain in congenital ornithine transcarbamylase deficiency.
Ratnakumari L; Qureshi IA; Butterworth RF
Neurosci Lett; 1994 Aug; 178(1):63-5. PubMed ID: 7816342
[TBL] [Abstract][Full Text] [Related]
19. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic M2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography.
Vilaró MT; Wiederhold KH; Palacios JM; Mengod G
Neuroscience; 1992; 47(2):367-93. PubMed ID: 1641129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
